Skip to main content
. 2022 Dec 21;15(1):27. doi: 10.3390/cancers15010027

Figure 2.

Figure 2

The STX6 level can sufficiently predict the prognosis of patients with cancer. Cox regression analysis showed that patients with high levels of STX6 showed a poor prognosis in DFI, DSS, OS, or PFI, especially patients with LIHC, ACC, PAAD, and KIRP, whereas OV and GBMLGG patients showed the opposite (AD).